Xiamen Amoytop Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	28,210	29,847	21,296	15,837	11,911	13,872
Market Cap Growth	-8.28%	40.15%	34.47%	32.96%	-14.13%	-
Enterprise Value	27,526	29,272	20,670	15,360	11,446	13,419
Last Close Price	69.11	72.76	51.54	38.13	28.57	33.22
PE Ratio	29.92	36.06	38.34	55.18	65.73	119.00
Forward PE	20.74	28.12	28.12	28.12	28.12	64.34
PS Ratio	8.44	10.60	10.14	10.37	10.52	17.47
PB Ratio	9.37	11.69	11.35	11.25	10.26	13.87
P/TBV Ratio	10.99	12.53	12.64	12.32	11.74	16.75
P/FCF Ratio	74.21	166.48	95.23	109.98	271.61	-
P/OCF Ratio	46.27	69.31	41.59	43.61	50.73	149.79
EV/Sales Ratio	8.24	10.39	9.84	10.06	10.11	16.90
EV/EBITDA Ratio	24.83	29.58	28.98	38.09	43.97	81.31
EV/EBIT Ratio	26.51	31.46	31.32	42.66	51.64	105.77
EV/FCF Ratio	72.41	163.28	92.42	106.67	260.99	-
Debt / Equity Ratio	0.05	0.00	0.00	0.01	0.02	0.02
Debt / EBITDA Ratio	0.13	0.01	0.01	0.02	0.10	0.11
Debt / FCF Ratio	0.37	0.05	0.04	0.07	0.57	-
Asset Turnover	1.03	1.04	1.02	0.96	0.87	0.80
Inventory Turnover	0.76	0.82	0.89	1.39	1.18	1.01
Quick Ratio	3.04	3.55	2.80	3.04	4.01	5.76
Current Ratio	3.84	4.34	3.32	3.57	4.71	6.72
Return on Equity (ROE)	35.63%	37.37%	33.83%	22.35%	16.77%	14.91%
Return on Assets (ROA)	20.06%	21.51%	19.99%	14.09%	10.59%	8.00%
Return on Invested Capital (ROIC)	43.34%	53.10%	55.56%	37.47%	29.64%	21.89%
Return on Capital Employed (ROCE)	32.40%	35.40%	33.80%	24.00%	17.80%	11.80%
Earnings Yield	3.33%	2.77%	2.61%	1.81%	1.52%	0.84%
FCF Yield	1.35%	0.60%	1.05%	0.91%	0.37%	-0.19%
Dividend Yield	0.90%	0.85%	0.80%	0.56%	0.35%	0.15%
Payout Ratio	26.86%	20.15%	15.60%	14.17%	11.41%	10.91%
Buyback Yield / Dilution	0.07%	-0.56%	-0.29%	-0.39%	-0.18%	-12.54%
Total Shareholder Return	0.96%	0.30%	0.50%	0.17%	0.18%	-12.38%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.